Research Nester released a report titled “Estrogen Replacement Therapy Market: Global Demand Analysis & Opportunity Outlook 2028” which delivers detailed overview of the global estrogen replacement therapy market in terms of market segmentation by route of administration and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Estrogen replacement therapy is a form of hormone replacement therapy (HR) in women which is required by post-menopausal women in order to relieve symptoms of menopause such as hot flashes, irregular sleeping patterns and vaginal dryness. The market for estrogen replacement therapy is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028. The market is segmented by route of administration and by region. On the basis of route of administration, the market is segmented into oral, topical, transdermal, vaginal and parenteral, out of which, the oral segment is anticipated to hold the largest share in the estrogen replacement therapy market on account of ease of administration of estrogen in the oral forms such as tablets and capsules. 

Based on region, the estrogen replacement therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to hold the largest share in the market as a result of growing population of post-menopausal women in the region. This is predicted to raise the demand for estrogen therapy in order to provide relief from the symptoms.

Relief from Menstrual Symptoms through Estrogen Therapy to Boost the Market Growth

As per a report published by the Centers for Disease Control and Prevention in 2017, around 27.1% of postmenopausal women between the ages 40 and 59 were highly likely to have trouble falling asleep as compared with premenopausal women. Moreover, about 55.1% of postmenopausal women aged between 40 and 59 were more likely than premenopausal women to wake up not feeling well rested for at least 4 days per week.

Rising awareness among women about the serious implications of menopause which can lead to disorders and discomfort has led to the increasing adoption of hormone therapies such as estrogen replacement therapy by women. As a result of growing patient population, the estrogen therapy market is anticipated to witness significantly high growth over the forecast period. However, the restrictions of estrogen therapy consisting of side effects and limited use is estimated to hamper the market growth.

This report also provides the existing competitive scenario of some of the key players of the global estrogen replacement therapy market which includes company profiling of Abbott Laboratories, Pfizer Inc., Novartis, Bayer Healthcare, Eli Lilly, Novo Nordisk, Merck, Allergan, Orion Pharma and TherapeuticsMD, Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global estrogen replacement therapy market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.